Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Arnaldez Website

Fernanda I. Arnaldez, M.D.

Selected Publications

1)  Arnaldez FI, Helman LJ.
New Strategies in Ewing"s Sarcoma: Lost in Translation?.
Clin. Cancer Res. 2014.
2)  Arnaldez F, Warren K.
Targeting Key Signaling Pathways in Pediatric Brain Tumors. In: Frontiers in Clinical Drug Research - Anti-Cancer Agents.
Oak Park, IL: Bentham Science Publishers; 2013. p. 1-26 [Book Chapter]
3)  Yeung CL, Ngo VN, Grohar PJ, Arnaldez FI, Asante A, Wan X, Khan J, Hewitt SM, Khanna C, Staudt LM, Helman LJ.
Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth.
Oncogene. 32: 5429-38, 2013.
4)  Darbari DS, Desai D, Arnaldez F, Desai K, Kallen J, Strouse J, Streiff MB, Hong K, Takemoto CM.
Safety and efficacy of catheter directed thrombolysis in children with deep venous thrombosis.
Br. J. Haematol. 159: 376-8, 2012.
5)  Arnaldez FI, Helman LJ.
Targeting the insulin growth factor receptor 1.
Hematol. Oncol. Clin. North Am. 26: 527-42, vii-viii, 2012.
Click Here to View Expanded Bibliography.

This page was last updated on 4/25/2014.